Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
A definitive Handbook for Securities exchange Money management - 2AfD in Brandenburg takes back suit against the intelligence service
- 3Display of Netanyahu's severed head 'incites public to murder PM', Likud says in official complaint
- 4Make Your Fantasy Closet: 10 Immortal Design Fundamentals
- 5This Week In Space podcast: Episode 204 — A New NASA
- Two separate Israeli espionage cases uncover Iran-linked activities in Jerusalem, Ashkelon
- Argentina reportedly delaying embassy move over Israeli company's oil project near Falklands
- German mid-sized firms gloomy on outlook, survey finds
- Yemen’s Aden airport shut by STC-backed transport minister, Saudi source says
- South Korea to End Bear Bile Farming and Find New Homes for the 200 Bears Stuck in the Industry
- An Ideal Getaway - Spots for Solo Travel
- These four astronauts could soon travel farther from Earth than anyone has gone before
- Tatiana Schlossberg's diagnosis puts spotlight on leukemia: What to know
- Some gifted dogs can learn new toy names by eavesdropping on owners
